Bariatric surgery covers operations on the stomach or intestine intended to treat severe obesity, such as sleeve gastrectomy or gastric bypass; the gastric balloon is a non-surgical endoscopic technique. It is part of overall medical care, with long-term nutritional and medical follow-up. Detailed journey: bariatric surgery →
Metabolic and bariatric surgery no longer only seeks weight loss. It aims for lasting improvement in health, with a strategy adapted to associated diseases, eating behavior, surgical risk and possible follow-up. Future innovations should above all better guide the patient in this journey.
In summary
The most likely advances are AI to estimate risks and response to treatment, endoscopic techniques without abdominal incision, robotics for certain complex cases and connected metabolic monitoring. Endoscopic sleeve gastroplasty is already a recognized option in selected indications. Devices acting on the intestine, personalization by the microbiota and automation of decisions remain at different stages of research.
At a glance: where each innovation stands
| Innovation | Current stage (according to this article) |
|---|---|
| AI to estimate risks and response to treatment | Among the most likely advances |
| Endoscopic techniques without abdominal incision | Likely advance; endoscopic sleeve gastroplasty is already a recognised option for selected indications |
| Robotics for certain complex cases | Among the most likely advances |
| Connected metabolic follow-up | Among the most likely advances |
| Devices acting on the intestine, microbiome-based personalisation, automated decisions | At various stages of research |
A future made up of several levels, not a single operation
Joint recommendations from endoscopy societies published in 2024 place certain endoscopic therapies in the arsenal against obesity, with lifestyle modification. This development creates a space between medical treatment and surgery. A patient could move from one level to another depending on their BMI, comorbidities, goals and initial response.
This diversity does not mean that the techniques are interchangeable. Surgery maintains specific effectiveness and decline for severe obesity; Endoscopic approaches meet other profiles and can offer less weight loss.
Can AI select and monitor better?
Machine learning models are being studied to predict complications, readmission, weight loss or improvement in diabetes. A systematic review from 2025 concludes that there is real potential, but highlights the retrospective nature of the studies, regional biases and the need for multicenter validations.
The most credible use in the short term is risk stratification: drawing the team's attention to a profile requiring reinforced respiratory, nutritional or cardiological preparation. The algorithm cannot decide alone, because patient preferences and tracking capacity cannot be reduced to a database.
Metabolic endoscopy broadens the scope of treatments
Endoscopic sleeve gastroplasty reshapes the stomach endoscopically. It is already practiced and benefits from a positioning based on data, particularly for certain patients who do not require or do not want surgery. Other gastric and intestinal devices seek to reproduce some of the anatomical or metabolic effects of surgery.
Research focuses on duodenal remodeling, endoluminal sleeves, incision-free magnetic anastomoses and combinations with obesity medications. Several solutions remain experimental or only available within specific regulatory frameworks.
Robotics: useful for complexity, not superior in principle
Robotic platforms provide vision, ergonomics and articulation of instruments. They can be interesting for revision surgery or complex anatomy. However, a meta-analysis comparing robotic and laparoscopic bypass did not show superiority in the main perioperative outcomes and noted a slightly higher reoperation rate in the pooled data.
The next innovation will therefore perhaps be less “more robot” than better criteria for choosing when its cost and operating time provide real value.
Metabolic monitoring becomes an intervention in its own right
After the procedure, the result depends on nutrition, activity, sleep, supplements and psychological support. Connected scales, questionnaires and activity data can reveal a break in trajectory. Smart systems could personalize reminders or trigger contact with a dietitian.
The microbiota is an active field, but today it does not allow the reliable choice of an individual operation or diet. The analyzes must demonstrate clinical utility, beyond interesting biological associations.
Three horizons of maturity
- Available: minimally invasive surgery, robotic assistance depending on the center, endoscopic gastroplasty in regulated indications.
- In validation: algorithmic prediction and personalized connected tracking programs.
- Experimental: several small intestine devices, personalization by microbiota and semi-automated pathways.
In Istanbul, check the complete route
For a bariatric surgery in Istanbul, the most important innovation often remains organizational: multidisciplinary assessment, justified technique, equipped establishment and continuity of monitoring. The patient must know who is monitoring deficiencies, how to contact the team and what consultations are planned after their return.
Estetic Univers can facilitate the organization, including information on partner hotels in Istanbul and connection. The therapeutic decision is made by the medical team after individual assessment.